NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS (AMENDMENTS) 1980 NO. 69 NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS (AMENDMENTS) 1980 NO. 69 - TABLE OF PROVISIONS 1. Commencement 2. Schedule 1 3. Schedule 2 4. Schedule 3 5. Schedule 5 SCHEDULE 1 SCHEDULE 2 SCHEDULE 3 SCHEDULE 4 1980 No. 69 NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS (AMENDMENTS) - REG 1 Commencement 1. These Regulations shall come into operation on 1 April 1980. 1980 No. 69 NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS (AMENDMENTS) - REG 2 Schedule 1 2. Schedule 1 to the National Health (Pharmaceutical Benefits) Regulations is amended as set out in Schedule 1. 1980 No. 69 NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS (AMENDMENTS) - REG 3 Schedule 2 3. Schedule 2 to the National Health (Pharmaceutical Benefits) Regulations is amended as set out in Schedule 2. 1980 No. 69 NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS (AMENDMENTS) - REG 4 Schedule 3 4. Schedule 3 to the National Health (Pharmaceutical Benefits) Regulations is amended as set out in Schedule 3. 1980 No. 69 NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS (AMENDMENTS) - REG 5 Schedule 5 5. Schedule 5 to the National Health (Pharmaceutical Benefits) Regulations is amended as set out in Schedule 4. ---------- 1980 No. 69 NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS (AMENDMENTS) - SCHEDULE 1 SCHEDULE 1 Regulation 2 AMENDMENTS OF SCHEDULE 1 TO THE NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS 1. After Item 49 insert the following item: "49A Belladonna Herb, Prepared". 2. After Item 108 insert the following item: "108A Chloroquine Phosphate". 3. After Item 257 insert the following item: "257A Ethopropazine Tablets". 4. After Item 373 insert the following item: "373A Lanatoside C". 5. After Item 411 insert the following item: "411A Meclozine Hydrochloride". 6. After Item 518 insert the following item: "518A Pancreatin". 7. After Item 539 insert the following item: "539A Pertussis Vaccine". ---------- 1980 No. 69 NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS (AMENDMENTS) - SCHEDULE 2 SCHEDULE 2 Regulation 3 AMENDMENTS OF SCHEDULE 2 TO THE NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS 1. Omit Item 10. 2. Omit Item 11. 3. Omit Item 13. 4. Omit Item 14. 5. After Item 56 insert the following items: "56A Chlortetracycline . . . . . -". "56B Chlortetracycline Hydrochloride . . . . . . . -". 6. Omit Item 89, substitute the following item: "89 Ergotamine Tartrate . . . . Caffeine Citrate with Diphenhydramine Hydrochloride and Ergotamine Tartrate Caffeine with Cyclizine Hydrochloride and Ergotamine Tartrate Caffeine with Ergotamine Tartrate". 7. Omit Item 110, substitute the following item: "110 Glucose and Ketone Indicator--Urine -". 8. Omit Item 117. 9. Omit Item 120, substitute the following item: "120 Hydrocortisone Acetate . . Neomycin Sulphate with Hydrocortisone Acetate". 10. Omit Item 121, substitute the following items: "121 Hyoscine Hydrobromide, B.P. Atropine Sulphate, B.P. with Hyoscyamine Hydrobromide, B.P. and Hyoscine Hydrobromide, B.P. Atropine Sulphate, B.P. with Hyoscyamine Sulphate and Hyoscine Hydrobromide, B.P. Papaveretum with Hyoscine Hydrobromide, B.P. "121A Hyoscyamine Hydrobromide . Atropine Sulphate, B.P. with Hyoscine Hydrobromide, B.P. and Hyoscyamine Hydrobromide". 11. Omit Item 140. 12. Omit Item 161, substitute the following item: "161 Oxytetracycline Hydrochloride, B.P. -". 13. Omit Item 163. 14. Omit Item 177, substitute the following item: "177 Polymyxin B Sulphate . . . Bacitracin with Neomycin Sulphate and Polymyxin B Sulphate Bacitracin Zinc with Neomycin Sulphate and Polymyxin B Sulphate Chloramphenicol with Polymyxin B Sulphate Neomycin Sulphate with Gramicidin and Polymyxin B Sulphate Neomycin Sulphate with Hydrocortisone and Polymyxin B Sulphate Propylene Glycol with Acetic Acid and Polymyxin B Sulphate". 15. Omit Item 188. ---------- 1980 No. 69 NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS (AMENDMENTS) - SCHEDULE 3 SCHEDULE 3 Regulation 4 AMENDMENTS OF SCHEDULE 3 TO THE NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS 1. Omit Item 21. 2. Omit Item 22. 3. Omit Item 24. 4. Omit Item 25. 5. After Item 76 insert the following item: "76A Chlortetracycline". 6. Omit Item 138, substitute the following item: "138 Glucose and Ketone Indicator-Urine". 7. After Item 154 insert the following item: "154A Hyoscyamine Hydrobromide". 8. Omit Item 267. ---------- 1980 No. 69 NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS (AMENDMENTS) - SCHEDULE 4 SCHEDULE 4 Regulation 5 AMENDMENTS OF SCHEDULE 5 TO THE NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS 1. Omit Item 36, substitute the following items: "36 Chlormethiazole . . . . . . With the written authority of the Permanent Head- Short-term hospital use for alcohol or drug withdrawal therapy Status epilepticus "36A Chlormethiazole Edisylate . Short-term hospital use for alcohol or drug withdrawal therapy Status epilepticus". 2. Omit Item 52, substitute the following item: "52 Danazol . . . . . . . . . . With the written authority of the Permanent Head- Endometriosis proven by laparoscopy or laparotomy Hereditary angio-oedema". 3. Omit Item 91, substitute the following item: "91 Influenza Vaccine . . . . . Prophylaxis of persons at special risk of adverse consequences from infections of the lower respiratory tract". 4. Omit Item 108, substitute the following item: "108 (1) Methadone Injection, B.P. (2) Methadone Tablets, B.P. Disabling pain associated with proven malignant neoplasia Disabling pain associated with self-limiting disorders of short duration not responding to non-narcotic analgesics, the maximum duration of treatment being two weeks". 5. Omit Item 136, substitute the following item: "136 (1) Pancreatin Enzyme 4X U.S.N.F. XIII strength Cystic fibrosis (mucoviscidosis) Following pancreatico-duodenectomy (2) Pancreatin Enzyme 5X U.S.N.F. XIV strength Pancreatic steatorrhoea". (3) Pancrelipase 6. Omit Item 138, substitute the following item: "138 Pentazocine Lactate Injection, B.P. . . . . . . Disabling pain associated with proven malignant neoplasia Disabling pain associated with self-limiting disorders of short duration not responding to non-narcotic analgesics, the maximum duration of treatment being two weeks". 7. After Item 161 insert the following item: "161A Pyrimethamine, B.P. with Sulfadoxine Prophylaxis or treatment of chloroquine-resistant falciparum malaria only". 8. Omit Item 190, substitute the following items: "190 Verapamil Hydrochloride Injection . . . . . . . . . Cardiac arrhythmias "190A Verapamil Hydrochloride Tablets . . . . . . . . . . With the written authority of the Permanent Head- Angina at rest (Prinzmetal) in patients who are not taking a beta blocking drug Angina associated with respiratory disease in patients who are not taking a beta blocking drug Cardiac arrhythmias in patients who are not taking a beta blocking drug". - NOTES 1980 No. 69 NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS*1* *2* (AMENDMENTS) *1* Notified in the Commonwealth of Australia Gazette on 31 March 1980. *2* Statutory Rules 1960 No. 17 as amended by Statutory Rules 1960 Nos. 90 and 102; 1961 Nos. 59 and 137; 1962 Nos. 34, 101 and 114; 1963 Nos. 34, 69 and 107; 1964 Nos. 12, 57 and 135; 1965 Nos. 51, 151 and 152; 1966 Nos. 80 and 144; 1967 Nos. 67, 116 and 158; 1968 Nos. 44, 76, 88 and 146; 1969 Nos. 44, 107 and 185; 1970 Nos. 39, 94, 119 and 186; 1971 Nos. 44, 101, 136 and 154; 1972 Nos. 32, 121 and 205; 1973 Nos. 15, 57, 139 and 229; 1974 Nos. 37, 126 and 222; 1975 Nos. 50, 148 and 209; 1976 Nos. 84, 150, 195 and 255; 1977 Nos. 39, 125 and 221; 1978 Nos. 47, 142, 153 and 245; 1979 Nos. 51, 55, 144 and 250.